U.S. Precision Oncology Market Size & Outlook, 2025-2030
Related Markets
U.S. precision oncology market highlights
- The U.S. precision oncology market generated a revenue of USD 45,159.4 million in 2024 and is expected to reach USD 79,841.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 10% from 2025 to 2030.
- In terms of segment, therapeutics was the largest revenue generating product in 2024.
- Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
Precision oncology market data book summary
| Market revenue in 2024 | USD 45,159.4 million |
| Market revenue in 2030 | USD 79,841.2 million |
| Growth rate | 10% (CAGR from 2025 to 2030) |
| Largest segment | Therapeutics |
| Fastest growing segment | Diagnostics |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | Thermo Fisher Scientific Inc, Invitae Corp, Qiagen NV, Illumina Inc, Exact Sciences Corp, Rain Oncology, Strata Oncology, Xilis, Variantyx, BioServe, Relay Therapeutics, Acrivon Therapeutics |
Other key industry trends
- In terms of revenue, U.S. accounted for 39.0% of the global precision oncology market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. precision oncology market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 79,841.2 million by 2030.
Therapeutics was the largest segment with a revenue share of 78.08% in 2024. Horizon Databook has segmented the U.S. precision oncology market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
The precision oncology market in the U.S. is projected to grow at a significant CAGR during the forecast period. Significant approvals for innovative treatment regimens for various cancers are one of the prime factors driving the market. For instance, AstraZeneca’s Imfinzi (durvalumab) received FDA approval in August 2024 for use with chemotherapy in treating resectable early-stage non-small cell lung cancer.
Based on the AEGEAN Phase III trial, the Imfinzi-based regimen reduced the risk of recurrence, progression, or death by 32% compared to neoadjuvant chemotherapy alone. Such advancements demonstrate the growing adoption of precision therapies that enhance survival rates, driving the demand for personalized cancer treatments in the U.S., and thereby fostering market growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Precision Oncology Market Scope
Precision Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Acrivon Therapeutics | View profile | 51-100 | Cambridge, Massachusetts, United States, North America | http://www.acrivon.com/ |
| Relay Therapeutics | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | http://relaytx.com/ |
| BioServe | View profile | 51-100 | Beltsville, Maryland, United States, North America | https://bioserve.com |
| Variantyx | View profile | 101-250 | Framingham, Massachusetts, United States, North America | https://www.variantyx.com |
| Xilis | View profile | 51-100 | Durham, North Carolina, United States, North America | http://www.xilis.net |
| Strata Oncology | View profile | 51-100 | Ann Arbor, Michigan, United States, North America | http://www.strataoncology.com/ |
| Rain Oncology | View profile | 101-250 | Newark, California, United States, North America | https://www.rainoncology.com |
| Invitae Corp | View profile | 1700 | 1400 16th Street, San Francisco, CA, United States, 94103 | https://www.invitae.com |
| Exact Sciences Corp | View profile | 6600 | 5505 Endeavor Lane, Madison, WI, United States, 53719 | https://www.exactsciences.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
US Product - Precision Oncology Market size, 2024 - 2030 (US$M)
U.S. Precision Oncology Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
